Back

10x Genomics wins $4.8 million patent verdict against Qiagen subsidiary

Verifying
  • 10x Genomics won a Delaware patent verdict against Qiagen subsidiary Parse Biosciences.
  • $4.8 million-plus reflects a 14% royalty on specified Evercode sales.
  • 10x acquired Scale Biosciences in 2025 and plans further U.S. legal action.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.